1Kowalski R,Post D, Schneider MC. Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management[J]. Clin Transplant, 2003,17 : 77.
2Buttgereit F, Burmester GR, Brand MD. Bioenergetics of immune functions: fundamental and therapeutic aspects[J]. Immunol To- day,2000,21(4) :192.
3Hooper E, Hawkins DM, Kowalski RJ, et al. Establishing pediat ric immune response zones using the Cylex Immuknow assayl-J]. Clin Transplant,2005,19(6) :834.
4Richald J,Konwalski, Dine R, et al. Assesing relative risks of in- fection and rejection: A meta-analysis using an immune function assay[J]. Transplantion, 2006,82 : 663.
5Zhou H. wu Z. Ma L, et al. Assessing immunologic function through CD4 T-lymphocyte ahenosine triphosphate Ievels by Im- muKnow assay in Chinese patients following renal Transplanta- tion[J]. Transplant Proc,2011,43(7) :2574.
7He J,Li Y,Zhang H,et al. Immune function assay (ImmuKnow)as a predictor of allograft reiection and infection in kidney taDs- plantation[J]. Clin Transplant, 2013,27(4) : E351.
9Cadillo-Chavez R,de Echegaray S, Santiago Delpin EA, et al. As sessing the risk of infection and rejection in Hispanic renal trans plant recipients by means of an adenosine trihosphate release as say[J]. Transplant Proc,2006,38(3) :918.
2Rocha PN, Butterly DW, Greenberg A, et al. Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection [ J ]. Transplantation, 2003, 75 : 1490-1495.
3Luke PP, Scantlebury VP, Jordan ML, et al. Reversal of steroid and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin(IVIG) in renal transplant recipients [ J ]. Transplantation, 2001, 72:419-422.
4Kowalski R,Post D,Schneider MC,et al.Immune cell function testing:an adjunct to therapeutic drug monitoring in transplant patient management.Clin Transplant,2003,17(2):77-88.
5Gautam A,Fischer SA,Yango AF,et al.Cell mediated immunity (CMI) and post transplant viral infections-role of a functional immune assay to titrate immunosuppression.Int Immunopharmacol,2006,6(13-14):2023-2026.
6Israeli M,Klein T,Sredni B,et al.ImmuKnow:a new parameter in immune monitoring of pediatric liver transplantation recipients.Liver Tranapl,2008,14 (6):893-898.
7Bhorade SM,Janata K,Vigneswaran WT,et al.Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection.J Heart Lung Transplant,2008,27 (9):990-994.
8Zeevi A,Britz JA,Bentlejewski CA,et al.Monitoring immune function during taerolimus tapering in small bowel transplant recipients.Transpl lmmunol,2005,15 (1):17-24.
9Thai NL,Blisard D,Tom K,et al.Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus:Correlation between low T-cell responses and intection.Transplantation,2006,82 (12):1649-1652.
